- Home
- /
- Vaccination
- /
- Respiratory Syncytial Virus ...
RSV Vaccine
Respiratory Syncytial Virus (RSV) is highly contagious and hard to be detected.
AREXVY (Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted) is a vaccine indicated for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY is for intramuscular injection only, preferably in the deltoid muscle
Who should consider vaccination
- People aged 60 or above, especially those with chronic disesases
Overall adverse drug reactions
| System Organ Class | Frequency | Adverse drug reactions |
| Blood and lymphatic system disorders | Uncommon | lymphadenopathy |
| Gastrointestinal disorders | Uncommon | nausea, abdominal pain |
| General disorders and administration site conditions | Very common | injection site pain, fatigue |
| Common | injection site erythema, injection site swelling, fever, chills | |
| Uncommon | injection site pruritus, pain, malaise | |
| Immune system disorders | Uncommon | hypersensitivity reactions (such as rash) |
| Musculoskeletal and connective tissue disorders | Very common | myalgia, arthralgia |
| Nervous system disorders | Very common | headache |
| Respiratory, thoracic, and mediastinal disorders | Common | rhinorrhea |
For enquiries, please contact
Tel: (852) 3160 4886
Email: neo@neohealth.com.hk
Health Screening
We provide a variety of plans to meet your needs. In addition to analyzing the medical report, we also care about your lifestyle and family medical history before giving professional medical advice. If you obtain abnormal test results, we can arrange for more detailed testing and high-quality treatment services to get early treatment and reduce the chance of recurrence.
9-valent HPV vaccine (Gardasil 9)
GARDASIL 9 is a vaccine for both females and males to prevent cervical, vulvar, vaginal, and anal cancers caused by human papillomavirus (HPV) Types 16, 18, 31, 33, 45, 52, and 58…